Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Studies show biological activity and tolerability of AZD-3409

Oct. 4, 2004

Preliminary clinical results reported for chimeric anti-alpha5beta1 MAb

Oct. 4, 2004

Daily oral CP-724714 well tolerated in first clinical study

Oct. 4, 2004

Selenophene derivative induces apoptosis in renal cancer cells

Oct. 4, 2004

Daily administration of A6 well tolerated in gynecological cancer patients

Oct. 4, 2004

AZD-2171 useful in combination with other antitumor agents

Oct. 4, 2004

Metvix approved in eight more European countries

Oct. 4, 2004

Cellular Genomics presents new Hsp90 modulators

Oct. 4, 2004

Millennium submits supplemental NDA for Velcade

Oct. 1, 2004

Pharmacyclics identifies potential development candidate from a series of sapphyrin derivatives

Oct. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...